🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The clinical feasibility of 18F-FAPI-RGD PET/CT will be evaluated in 100 pa...
Status
Unknown
Location
Departments of Nuclear Medicine, Sichuan Provincial People's Hospital
Start Date
2023-04-10
Trial ID
NCT06094530
To explore the potential utility of 18F-FAPI-04 PET/CT for pathologic respo...
Status
Completed
Location
First Affiliated Hospital, Medical College of Zhejiang University
Start Date
2021-08-04
Trial ID
NCT06277206
Treatments Being Tested
Fibroblast-activation protein (FAP) is a type Ⅱ transmembrane serine protea...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2021-02-23
Trial ID
NCT05034146
The goal of this clinical trial is to investigate whether new imaging techn...
Status
Recruiting
Location
University Hospital Zurich
Start Date
2025-10-20
Trial ID
NCT07112066
Treatments Being Tested
Evaluating fluoro-18-fibroblast activation protein inhibitor-04 positron em...
Status
Completed
Location
The Second Hospital of Lanzhou University
Start Date
2022-04-01
Trial ID
NCT06206642
Treatments Being Tested
This study intends to use a prospective, observational, self-controlled, mu...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2023-11-21
Trial ID
NCT06164561
The aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/...
Status
Recruiting
Location
first hospital affiliated of Fujian medical university
Start Date
2024-08-02
Trial ID
NCT06421142
Treatments Being Tested
Gastric cancer is the fifth most common cancer worldwide and the third lead...
Status
Recruiting
Location
Department of Nuclear Medicine, Daping Hospital of Army Medical University
Start Date
2024-01-01
Trial ID
NCT06327386
Treatments Being Tested
This is a multi-site, open-label, non-randomized, single dose study to asse...
Status
Recruiting
Location
Helios CR Inc./RadNet
Start Date
2025-12-11
Trial ID
NCT07217717
Treatments Being Tested
Main objective: 1\. To compare the objective response rate (ORR) of 18F-FA...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-08-07
Trial ID
NCT07079462
Treatments Being Tested